Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort

Southern African Journal of HIV Medicine

Gary Maartens¹  Shaazia Allie²  Mohamed F. Chughlay²  Hannah Gunter²  Mashiko Setshedi²  Sean Wasserman³  David F. Stead⁴  Karen Cohen⁵  Muhammed Shiraz Moosa⁵ 

[1] and, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town;Department of Medicine, Division of Clinical Pharmacology, Faculty of Health Sciences, University of Cape Town, Cape Town;Department of Medicine, Division of Gastroenterology, Faculty of Health Sciences, University of Cape Town, Cape Town;Department of Medicine, Division of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town;Department of Medicine, New Somerset Hospital, Cape Town, South Africa;

关键词: tuberculosis;    anti-tuberculosis drugs;    drug-induced liver injury;    positive rechallenge;    pyrazinamide;    treatment interruption;   

DOI  :  10.4102/sajhivmed.v23i1.1376

来源: DOAJ

【 授权许可】

Unknown